Clinical Trials Browser

OTHER × Glioma × Immunotherapy, Adoptive × Clear all

NCT03423992 2021-06-15

Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas

Phase 1 Unknown

Glioma, Recurrence

NCT02575261 2020-07-16

CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients

Phase 1/2 Withdrawn

Glioma

NCT03252171 2020-07-16

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

Phase 1/2 Withdrawn

Glioma